Selected research
Industry Research
Keratosis Pilaris Treatment Industry Research Report 2026
Market perspective
The global Keratosis Pilaris Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Keratosis Pilaris Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Keratosis Pilaris Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Keratosis Pilaris Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Keratosis Pilaris Treatment include AmLactin (Novartis), CeraVe (L'Oréal), DERMAdoctor, Eucerin (Beiersdorf AG), Excipial (Galderma), First Aid Beauty (P&G), Neutrogena (Johnson & Johnson), Nip + Fab and Paula’s Choice, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Keratosis Pilaris Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Keratosis Pilaris Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Keratosis Pilaris Treatment Market by Company
AmLactin (Novartis)
CeraVe (L'Oréal)
DERMAdoctor
Eucerin (Beiersdorf AG)
Excipial (Galderma)
First Aid Beauty (P&G)
Neutrogena (Johnson & Johnson)
Nip + Fab
Paula’s Choice
SLMD Skincare
Touch Skin Care
Keratosis Pilaris Treatment Segment by Type
Body Scrub
Lotion
Body Wash & Shower Gel
Other
Keratosis Pilaris Treatment Segment by Application
For Body
For Facial Skin
Keratosis Pilaris Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Keratosis Pilaris Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Keratosis Pilaris Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Keratosis Pilaris Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Keratosis Pilaris Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Body Scrub
- Lotion
- Body Wash & Shower Gel
- Other
Applications
- For Body
- For Facial Skin
Companies covered
- AmLactin (Novartis)
- CeraVe (L'Oréal)
- DERMAdoctor
- Eucerin (Beiersdorf AG)
- Excipial (Galderma)
- First Aid Beauty (P&G)
- Neutrogena (Johnson & Johnson)
- Nip + Fab
- Paula’s Choice
- SLMD Skincare
- Touch Skin Care
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Keratosis Pilaris Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Body Scrub
- 2.2.3 Lotion
- 2.2.4 Body Wash & Shower Gel
- 2.2.5 Other
- 2.3 Keratosis Pilaris Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 For Body
- 2.3.3 For Facial Skin
- 2.4 Assumptions and Limitations
3 Keratosis Pilaris Treatment Breakdown Data by Type
- 3.1 Global Keratosis Pilaris Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Keratosis Pilaris Treatment Forecasted Market Size by Type (2027-2032)
4 Keratosis Pilaris Treatment Breakdown Data by Application
- 4.1 Global Keratosis Pilaris Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Keratosis Pilaris Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Keratosis Pilaris Treatment Market Perspective (2021-2032)
- 5.2 Global Keratosis Pilaris Treatment Growth Trends by Region
- 5.2.1 Global Keratosis Pilaris Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Keratosis Pilaris Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Keratosis Pilaris Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Keratosis Pilaris Treatment Market Dynamics
- 5.3.1 Keratosis Pilaris Treatment Industry Trends
- 5.3.2 Keratosis Pilaris Treatment Market Drivers
- 5.3.3 Keratosis Pilaris Treatment Market Challenges
- 5.3.4 Keratosis Pilaris Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Keratosis Pilaris Treatment Players by Revenue
- 6.1.1 Global Top Keratosis Pilaris Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Keratosis Pilaris Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Keratosis Pilaris Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Keratosis Pilaris Treatment Head Office and Area Served
- 6.4 Global Keratosis Pilaris Treatment Players, Product Type & Application
- 6.5 Global Keratosis Pilaris Treatment Manufacturers Established Date
- 6.6 Global Keratosis Pilaris Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Keratosis Pilaris Treatment Market Size (2021-2032)
- 7.2 North America Keratosis Pilaris Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Keratosis Pilaris Treatment Market Size by Country (2021-2026)
- 7.4 North America Keratosis Pilaris Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Keratosis Pilaris Treatment Market Size (2021-2032)
- 8.2 Europe Keratosis Pilaris Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Keratosis Pilaris Treatment Market Size by Country (2021-2026)
- 8.4 Europe Keratosis Pilaris Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Keratosis Pilaris Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Keratosis Pilaris Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Keratosis Pilaris Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Keratosis Pilaris Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Keratosis Pilaris Treatment Market Size (2021-2032)
- 10.2 South America Keratosis Pilaris Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Keratosis Pilaris Treatment Market Size by Country (2021-2026)
- 10.4 South America Keratosis Pilaris Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Keratosis Pilaris Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Keratosis Pilaris Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AmLactin (Novartis)
- 12.1.1 AmLactin (Novartis) Company Information
- 12.1.2 AmLactin (Novartis) Business Overview
- 12.1.3 AmLactin (Novartis) Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.1.4 AmLactin (Novartis) Keratosis Pilaris Treatment Product Portfolio
- 12.1.5 AmLactin (Novartis) Recent Developments
- 12.2 CeraVe (L'Oréal)
- 12.2.1 CeraVe (L'Oréal) Company Information
- 12.2.2 CeraVe (L'Oréal) Business Overview
- 12.2.3 CeraVe (L'Oréal) Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.2.4 CeraVe (L'Oréal) Keratosis Pilaris Treatment Product Portfolio
- 12.2.5 CeraVe (L'Oréal) Recent Developments
- 12.3 DERMAdoctor
- 12.3.1 DERMAdoctor Company Information
- 12.3.2 DERMAdoctor Business Overview
- 12.3.3 DERMAdoctor Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.3.4 DERMAdoctor Keratosis Pilaris Treatment Product Portfolio
- 12.3.5 DERMAdoctor Recent Developments
- 12.4 Eucerin (Beiersdorf AG)
- 12.4.1 Eucerin (Beiersdorf AG) Company Information
- 12.4.2 Eucerin (Beiersdorf AG) Business Overview
- 12.4.3 Eucerin (Beiersdorf AG) Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.4.4 Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Product Portfolio
- 12.4.5 Eucerin (Beiersdorf AG) Recent Developments
- 12.5 Excipial (Galderma)
- 12.5.1 Excipial (Galderma) Company Information
- 12.5.2 Excipial (Galderma) Business Overview
- 12.5.3 Excipial (Galderma) Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.5.4 Excipial (Galderma) Keratosis Pilaris Treatment Product Portfolio
- 12.5.5 Excipial (Galderma) Recent Developments
- 12.6 First Aid Beauty (P&G)
- 12.6.1 First Aid Beauty (P&G) Company Information
- 12.6.2 First Aid Beauty (P&G) Business Overview
- 12.6.3 First Aid Beauty (P&G) Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.6.4 First Aid Beauty (P&G) Keratosis Pilaris Treatment Product Portfolio
- 12.6.5 First Aid Beauty (P&G) Recent Developments
- 12.7 Neutrogena (Johnson & Johnson)
- 12.7.1 Neutrogena (Johnson & Johnson) Company Information
- 12.7.2 Neutrogena (Johnson & Johnson) Business Overview
- 12.7.3 Neutrogena (Johnson & Johnson) Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.7.4 Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Product Portfolio
- 12.7.5 Neutrogena (Johnson & Johnson) Recent Developments
- 12.8 Nip + Fab
- 12.8.1 Nip + Fab Company Information
- 12.8.2 Nip + Fab Business Overview
- 12.8.3 Nip + Fab Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.8.4 Nip + Fab Keratosis Pilaris Treatment Product Portfolio
- 12.8.5 Nip + Fab Recent Developments
- 12.9 Paula’s Choice
- 12.9.1 Paula’s Choice Company Information
- 12.9.2 Paula’s Choice Business Overview
- 12.9.3 Paula’s Choice Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.9.4 Paula’s Choice Keratosis Pilaris Treatment Product Portfolio
- 12.9.5 Paula’s Choice Recent Developments
- 12.10 SLMD Skincare
- 12.10.1 SLMD Skincare Company Information
- 12.10.2 SLMD Skincare Business Overview
- 12.10.3 SLMD Skincare Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.10.4 SLMD Skincare Keratosis Pilaris Treatment Product Portfolio
- 12.10.5 SLMD Skincare Recent Developments
- 12.11 Touch Skin Care
- 12.11.1 Touch Skin Care Company Information
- 12.11.2 Touch Skin Care Business Overview
- 12.11.3 Touch Skin Care Revenue in Keratosis Pilaris Treatment Business (2021-2026)
- 12.11.4 Touch Skin Care Keratosis Pilaris Treatment Product Portfolio
- 12.11.5 Touch Skin Care Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst